Anti-Influenza A hemagglutinin Therapeutic Antibody (Diridavumab (CR6261))
Recombinant human monoclonal antibody expressed in CHO binding to Influenza A hemagglutinin. CR6261 is a monoclonal antibody that binds to a broad range of the influenza virus. Based upon the conservation of the amino acid sequence on this part of hemagglutinin, CR6261 is predicted to neutralize roughly 50% of all flu viruses.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-735 |
| Pricing | Inquiry |
| Host | Human |
| Target | Influenza A hemagglutinin |
| Species Reactivity | influenza virus |
| Type | IgG1 - lambda |
| Applications | Neut, ELISA, IF, IP, FuncS, FC, IHC |
| Storage | At -20°C for one year. |